During the past decade, Centre De Recherche Appliquée en Allergie De Quebec conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre De Recherche Appliquée en Allergie De Quebec" #1 sponsor was "Circassia Limited" with 3 trials, followed by "Allergy Therapeutics" with 2 trials sponsored, "DBV Technologies" with 1 trials sponsored, "Dynavax Technologies Corporation" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre De Recherche Appliquée en Allergie De Quebec" #1 collaborator was "Adiga Life Sciences, Inc." with 3 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centre De Recherche Appliquée en Allergie De Quebec" are "Type I Hypersensitivity" (2 trials), "Allergic Rhinitis" (1 trials), "Allergy" (1 trials), "Asthma" (1 trials) and "Peanut Allergy" (1 trials). Many other conditions were trialed in "Centre De Recherche Appliquée en Allergie De Quebec" in a lesser frequency.

Most popular intervention types in "Centre De Recherche Appliquée en Allergie De Quebec" are "Biological" (7 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Amb a 1 Immunostimulatory Oligoribonucleotide Conjugate" (1 trials), "Birch-SPIRE" (1 trials), "Grass MATA MPL" (1 trials) and "Grass-SPIRE" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre De Recherche Appliquée en Allergie De Quebec" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Centre De Recherche Appliquée en Allergie De Quebec". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Centre De Recherche Appliquée en Allergie De Quebec, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre De Recherche Appliquée en Allergie De Quebec, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".